Boulos Zacharie Boulos Zacharie is the director of chemistry at ProMetic BioSciences Inc., a global biopharmaceutical company and a leading drug developer in the fields of hematology, oncology, and nephrology. Boulos joined ProMetic BioSciences Inc. in 2001, bringing over twenty four years of experience that encompasses research and administration. On a daily basis, he oversees the work of research scientists (Ph.D. and M.S.), conducts the chemistry program, and participates in clinical trials. Prior to accepting his current position, Boulos worked at Biochem Pharmaceuticals, where he participated in the synthesis of two drugs currently on the market, 3TC and lamivudine. Boulos has been recognized with several honors, including the Prix Galien Canada Research Award for his contributions to the pharmaceutical industry. He has published over sixty-five papers and patents and is an editor for “Mini Reviews in Medicinal Chemistry”. He holds a PhD from University of Montreal (Canada), post doctoral degree and a management degree from McGill University.
Biography Updated on 1 November 2010